Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 13, 2013 - Issue 7
Submit an article Journal homepage
156
Views
6
CrossRef citations to date
0
Altmetric
Theme: Infectious Diseases - Review

Molecular HIV screening

Thomas BourletGroupe Immunité des Muqueuses et Agents Pathogènes (GIMAP) - EA3064, Faculty of Medicine of Saint-Etienne, 42023, University of Lyon, France;Laboratoire de Bactériologie-Virologie-Hygiène, Hôpital Nord, CHU de Saint-Etienne, 42055, France
,
Meriam MemmiGroupe Immunité des Muqueuses et Agents Pathogènes (GIMAP) - EA3064, Faculty of Medicine of Saint-Etienne, 42023, University of Lyon, France
,
Henia SaoudinLaboratoire de Bactériologie-Virologie-Hygiène, Hôpital Nord, CHU de Saint-Etienne, 42055, France
&
Bruno PozzettoGroupe Immunité des Muqueuses et Agents Pathogènes (GIMAP) - EA3064, Faculty of Medicine of Saint-Etienne, 42023, University of Lyon, France;Laboratoire de Bactériologie-Virologie-Hygiène, Hôpital Nord, CHU de Saint-Etienne, 42055, FranceCorrespondence[email protected]
Pages 693-705 | Published online: 09 Jan 2014

References

  • Barré-Sinoussi F, Chermann JC, Rey F et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220, 868–871 (1983).
  • Bentsen C, McLaughlin L, Mitchell E et al. Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma. J. Clin. Virol. 52, S57–S61 (2011).
  • Chavez P, Wesolowski L, Patel P, Delaney K, Owen SM. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay. J. Clin. Virol. 52, S51–S55 (2011).
  • Weber B. Screening of HIV infection: role of molecular and immunological assays. Expert Rev. Mol. Diagn. 6, 399–411 (2006).
  • Fiebig EW, Wright DJ, Rawal BD et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17, 1871–1879 (2003).
  • Humar A, Morris M, Blumberg E. Nucleic acid testing (NAT) of organ donors: is the « best » test the right test? A consensus conference report. Am. J. Transplant. 10, 889–899 (2010).
  • Tang YW, Ou CY. Past, present and future molecular diagnosis and characterization of human immunodeficiency virus infections. Emerg. Microbes. Infect. 1, e19 (2012).
  • Alvarez M, Chueca N, Guillot, del Carmen Bernal M, García F. Improving clinical laboratory efficiency: introduction of systems for the diagnosis and monitoring of HIV infection. Open Virol. J. 6, 135–143 (2012).
  • Mellors JW, Rinaldo CR, Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272, 1167–1170 (1996).
  • Mellors JW, Muñoz A, Giorgi JV et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med. 126, 946–954 (1997).
  • Karasi JC, Dziezuk F, Quennery L et al. High correlation between the Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes. J. Clin. Virol. 52, 181–186 (2011).
  • Xu S, Song A, Li X et al. Performance of the Abbott RealTime HIV-1 assay for quantification of HIV-1 clades prevalent in China. J. Clin. Virol. 41, 305–309 (2008).
  • Gomes P, Carvalho AP, Diogo I et al. Comparison of the NucliSENS EasyQ HIV-1 v2.0 with Abbott m2000rt RealTime HIV-1 assay for plasma RNA quantitation in different HIV-1 subtypes. J. Virol. Methods 193, 18–22 (2013).
  • Garcia-Diaz A, Labbett W, Clewley GS, Guerrero-Ramos A, Geretti AM. Comparative evaluation of the Artus HIV-1 QS-RGQ assay and the Abbott RealTime HIV-1 assay for the quantification of HIV-1 RNA in plasma. J. Clin. Virol. 57, 66–69 (2013).
  • Rouet F, Ekouevi DK, Chaix ML et al. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting. J. Clin. Microbiol. 43, 2709–2717 (2005).
  • Rouet F, Liégeois F, Mouinga-Ondémé A et al. Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1. Expert Opin. Med. Diagn. 5, 183–202 (2011).
  • Clerc O, Greub G. Routine use of point-of-care tests: usefulness and application in clinical microbiology. Clin. Microbiol. Infect. 16, 1054–1061( 2010).
  • Niemz A, Ferguson TM, Boyle DS. Point-of-care nucleic acid testing for infectious diseases. Trends Biotechnol. 29, 240–250 (2011).
  • Wassenberg M, Kluytmans J, Erdkamp S et al. Costs and benefits of rapid screening of methicillin-resistant Staphylococcus aureus carriage in intensive care units: a prospective multicenter study. Crit. Care 16, R22 (2012).
  • Meyer-Rath G, Schnippel K, Long L et al. The impact and cost of scaling up GeneXpert MTB/RIF in South Africa. PLoS ONE 7, e36966 (2012).
  • Palamountain KM, Baker J, Cowan EP et al. Perspectives on introduction and implementation of new point-of-care diagnostic tests. J. Infect. Dis. 205, S181–S190 (2012).
  • Tanriverdi S, Chen L, Chen S. A rapid and automated sample-to-result HIV load test for near-patient application. J. Infect. Dis. 201, S52–S58 (2010).
  • Lee HH, Dineva MA, Chua YL, Ritchie AV, Ushiro-Lumb I, Wisniewski CA. Simple amplification-based assay: a nucleic acid-based point-of-care platform for HIV-1 testing. J. Infect. Dis. 201, S65–S72 (2010).
  • Busch MP, Glynn SA, Stramer SL et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 45, 254–264 (2005).
  • Margaritis AR, Brown SM, Seed CR, Kiely P, D'Agostino B, Keller AJ. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Transfusion 47, 1783–1793 (2007).
  • Assal A, Barlet V, Deschaseaux M et al. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels. Transfusion 49, 301–310 (2009).
  • Roth WK, Busch MP, Schuller A et al. International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox. Sang. 102, 82–90 (2012).
  • Morel P. Dix ans de diagnostic génomique viral : leçons et perspectives. Trans. Clin. Biol. 18, 133–139 (2011).
  • Barlet V. Évolutions technologiques en qualification biologique du don et leur impact sur le risque résiduel transfusionnel. Trans. Clin. Biol. 18, 292–301 (2011).
  • Pillonel J, Laperche S, Saura C, Desenglos JC, Courouce AM, Transfusion-Transmissible Agents Working Group of the French Society of Blood Transfusion. Trends in residual risk of transfusion-transmitted viral infections in France between 1992 and 2000. Transfusion 42, 980–998 (2002).
  • Assal A, Coste J, Barlet V et al. Application de la biologie moléculaire à la sécurité virale transfusionnelle : le dépistage génomique viral. Transfus. Clin. Biol. 10, 217–226 (2003).
  • Najiouallah F, Barlet V, Renaudier P et al. Failure and success of HIV tests for the prevention of HIV-1 transmission by blood and tissue donation. J. Med. Virol. 73, 347–349 (2004).
  • Delwart EL, Kalmin ND, Jones TS et al. First report of HIV transmission via an RNA screened blood donation. Vox. Sang. 86, 171–177 (2004).
  • Phelps R, Robbins K, Liberti T et al. Window-period HIV transmission to two recipients by an adolescent donor. Transfusion 44, 929–933 (2004).
  • Ferreira MC, Nel TJ. Differential transmission of human immunodeficiency virus (HIV) via blood components from an HIV-infected donor. Transfusion 46, 156–157 (2006).
  • Harritshoj LH, Dickmeiss E, Hansen MB, Ullum H, Jorgensen LB, Gerstoft J. Transfusion-transmitted human immunodeficiency virus infection by a Danish blood donor with a very low viral load in the preseroconversion window phase. Transfusion 48, 2026–2028 (2008).
  • Schmidt M, Korn K, Nübling CM et al. First transmission of human immunodeficiency virus Type 1 by a cellular product after mandatory nucleic acid screening in Germany. Transfusion 49, 1836–1844 (2009).
  • Jackson BR, Busch MP, Stramer SL, AuBuchon JP. The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 43, 721–729 (2003).
  • Hourfar MK, Jork C, Schottstedt V et al. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Transfusion 48, 1558–1566 (2008).
  • Simonds RJ. HIV transmission by organ and tissue transplantation. AIDS 7, S35–S38 (1993).
  • Ahn J, Cohen SM. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation. Liver Transpl. 14, 1603–1608 (2008).
  • Ison MG, Llata E, Conover CS et al. Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients. Am. J. Transplant. 11, 1218–1225 (2011).
  • Schratt HE, Regel G, Kiesewetter B, Tscherne H. HIV-Infektion durch kältekonservierte Knochentransplantate. Unfallchirurg 9, 679–684 (1996).
  • Centers for Disease Control and Prevention (CDC). Transmission of HIV through bone transplantation: case report and public health recommendations. Morbid. Mortal. Wkly. Rep. 37, 597–599 (1988).
  • Simonds RJ, Holmberg SD, Hurwitz RL. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N. Engl. J. Med. 326, 726–732 (1992).
  • Clarke JA. HIV transmission and skin grafts. Lancet i, 983 (1987).
  • Li CM, Ho YR, Liu YC. Transmission of human immunodeficiency virus through bone transplantation: a case report. J. Formosan. Med. Assoc. 100, 350–351 (2001).
  • Pruss A, Caspari G, Krüger DH et al. Tissue donation and virus safety: more nucleic acid amplification testing is needed. Transpl. Infect. Dis. 12, 375–386 (2010).
  • Wingfield M, Cottell E. Viral screening of couples undergoing partner donation in assisted reproduction with regard to EU Directives 2004/23/EC, 2006/17/EC and 2006/86/EC: what is the evidence for repeated screening? Hum. Reprod. 25, 3058–3065 (2010).
  • Practice Committee of American Society for Reproductive Medicine. Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion. Fertil. Steril. 99, 340–346 (2013).
  • Bourlet T, Cazorla C, Berthelot P et al. Compartmentalization of HIV-1 according to antiretroviral therapy: viral loads are correlated in blood and semen but poorly in blood and saliva. AIDS 15, 284–285 (2001).
  • Dunne AL, Mitchell F, Allen KM et al. Analysis of HIV-1 viral load in seminal plasma samples. Clin. Virol. 26, 239–245 (2003).
  • Garrido N, Meseguer M, Simon C, Pellicer A, Remohi J. Assisted reproduction in HIV and HCV infected men of serodiscordant couples. Arch. Andro. 50, 105–111 (2004).
  • Tachet A, Dulioust E, Salmon D et al. Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS 13, 823–831 (1999).
  • Lesage B, Vannin AS, Emiliani S, Debaisieux L, Englert Y, Liesnard C. Development and evaluation of a qualitative reverse-transcriptase nested polymerase chain reaction protocol for same-day viral validation of human immunodeficiency virus type 1 ribonucleic acid in processed semen. Fertil. Steril. 86, 121–128 (2006).
  • Pasquier C, Anderson D, Andreutti-Zaugg C et al. Multicenter quality control of the detection of HIV-1 genome in semen before medically assisted procreation. J. Med. Virol. 78, 877–882 (2006).
  • Lorello G, la Porte C, Pilon R, Zhang G, Karnauchow T, MacPherson P. Discordance in HIV-1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma. HIV Med. 10, 548–554 (2009).
  • Pasquier C, Sauné K, Raymond S et al. Determining seminal plasma human immunodeficiency virus type 1 load in the context of efficient highly active antiretroviral therapy. J. Clin. Microbiol. 47, 2883–2887 (2009).
  • Pasquier C, Andreutti C, Bertrand E et al. Multicenter assessment of HIV-1 RNA quantitation in semen in the CREAThE network. J. Med. Virol. 84, 183–187 (2012).
  • Chan DJ, Mc Nally L. Assays for the determination of HIV-1 load in semen: a review of indications, methods and performance in vitro. Curr. HIV Res. 6, 182–188 (2008).
  • Fiore JR, Lorusso F, Vacca M, Ladisa N, Greco P, De Palo R. The efficiency of sperm washing in removing human immunodeficiency virus type 1 varies according to the seminal viral load. Fertil. Steril. 84, 232–234 (2005).
  • Politch JA, Xu C, Tucker L, Anderson DJ. Separation of human immunodeficiency virus type 1 from motile sperm by the double tube gradient method versus other methods. Fertil. Steril. 81, 440–447 (2004).
  • Vitorino RL, Grinsztejn BG, de Andrade CA et al. Systematic review of the effectiveness and safety of assisted reproduction techniques in couples serodiscordant for human immunodeficiency virus where the man is positive. Fertil. Steril. 95, 1684–1690 (2011).
  • Bujan L, Hollander L, Coudert M et al. Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS 21, 1909–1914 (2007).
  • van Rossum AM, Fraaij PL, de Groot R. Efficacy of highly active antiretroviral therapy in HIV-1 infected children. Lancet Infect. Dis. 2, 93–102 (2002).
  • Resino S, Resino R, Maria Bellon J et al. Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children. Clin. Infect. Dis. 43, 243–252 (2006).
  • Rouet F, Montcho C, Rouzioux C et al. Early diagnosis of paediatric HIV-1 infection among African breast-fed children using a quantitative plasma HIV RNA assay. AIDS 15, 1849–1856 (2001).
  • Sherman GG, Cooper PA, Coovadia AH et al. Polymerase chain reaction for diagnosis of human immunodeficiency virus infection in infancy in low resource settings. Pediatr. Infect. Dis. J. 24, 993–997 (2005).
  • Stevens WS, Noble L, Berrie L, Sarang S, Scott LE. Ultra-high-throughput, automated nucleic acid detection of human immunodeficiency virus (HIV) for infant infection diagnosis using the Gen-Probe Aptima HIV-1 screening assay. J. Clin. Microbiol. 47, 2465–2469 (2009).
  • Owen SM, Yang C, Spira T et al. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J. Clin. Microbiol. 46, 1588–1595 (2008).
  • Anoje C, Aiyenigba B, Suzuki C et al. Reducing mother-to-child transmission of HIV: findings from an early infant diagnosis program in south-south region of Nigeria. BMC Public Health 12, 184 (2012).
  • Okonji JA, Basavaraju SV, Mwangi J et al. Comparison of HIV-1 detection in plasma specimens and dried blood spots using the Roche COBAS Ampliscreen HIV-1 test in Kisumu, Kenya. J. Virol. Meth. 179, 21–25 (2012).
  • Torpey K, Mandala J, Kasonde P et al. Analysis of HIV early infant diagnosis data to estimate rates of perinatal HIV transmission in Zambia. PLoS ONE 7, e42859 (2012).
  • Delamare C, Burgard M, Mayaux MJ et al. HIV-1 RNA detection in plasma for the diagnosis of infection in neonates. The French Pediatric HIV Infection Study Group. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 15, 121–125 (1997).
  • Lilian RR, Kalk E, Bhowan K et al. Early diagnosis of in utero and intrapartum HIV infection in infants prior to 6 weeks of age. J. Clin. Microbiol. 50, 2373–2377 (2012).
  • Burgard M, Blanche S, Jasseron C. Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during antiretroviral prophylaxis. J. Pediatr. 160, 60–66 (2012).
  • Bremer JW, Lew JF, Cooper E et al. Diagnosis of infection with human immunodeficiency virus type 1 by a DNA polymerase chain reaction assay among infants enrolled in the Women and Infants' Transmission Study. J. Pediatr. 129, 198–207 (1996).
  • Kovacs A, Xu J, Rasheed S et al. Comparison of a rapid nonisotopic polymerase chain reaction assay with four commonly used methods for the early diagnosis of human immunodeficiency virus type 1 infection in neonates and children. Pediatr. Infect. Dis. J. 14, 948–954 (1995).
  • Midani S, Rathore MH. Polymerase chain reaction testing for early detection of HIV infection in children. South Med. J. 90, 294–295 (1997).
  • Lilian RR, Bhowan K, Sherman GG. Early diagnosis of human immunodeficiency virus-1 infection in infants with the NucliSens EasyQ assay on dried blood spots. J. Clin. Virol. 48, 40–43 (2010).
  • Kébé K, Ndiaye O, Ndiaye HD et al. RNA versus DNA (NucliSENS EasyQ HIV-1 v1.2 versus Amplicor HIV-1 DNA Test v1.5) for early diagnosis of HIV-1 infection in infants in Senegal. J. Clin. Microbiol. 49, 2590–2593 (2011).
  • Boyle DS, Lehman DA, Lillis L et al. Rapid detection of HIV-1 proviral DNA for early infant diagnosis using recombinase polymerase amplification. mBio 4, e00135–13 (2013).
  • Tejiokem MC, Faye A, Penda IC et al. Feasibility of early infant diagnosis of HIV in resource-limited settings: the ANRS 12140-PEDIACAM study in Cameroon. PLoS ONE 6, e21840 (2011).
  • Lofgren SM, Morrissey AB, Chevallier CC et al. Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities. AIDS 23, 2459–2466 (2009).
  • Nkenfou CN, Lobé EE, Ouwe-Missi-Oukem-Boyer O et al. Implementation of HIV early infant diagnosis and HIV type 1 RNA viral load determination on dried blood spots in Cameroon: challenges and propositions. AIDS Res. Hum. Retroviruses 28, 176–181 (2012).
  • Kerr RJ, Player G, Fiscus SA, Nelson JA. Qualitative human immunodeficiency virus RNA analysis of dried blood spots for diagnosis of infections in infants. J. Clin. Microbiol. 47, 220–222 (2009).
  • Sherman GG, Stevens G, Jones SA, Horsfield P, Stevens WS. Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings. J. Acquir. Immune. Defic. Syndr. 38, 615–617 (2005).
  • Viljoen J, Gampini S, Danaviah S et al. Dried blood spot HIV-1 RNA quantification using open real-time systems in South Africa and Burkina Faso. J. Acquir. Immune. Defic. Syndr. 55, 290–298 (2010).
  • Huang S, Erickson B, Mak WB, Salituro J, Abravaya K. A novel RealTime HIV-1 Qualitative assay for the detection of HIV-1 nucleic acids in dried blood spots and plasma. J. Virol. Methods 178, 216–224 (2011).
  • Comeau AM, Pitt J, Hillyer GV et al. Early detection of human immunodeficiency virus on dried blood spot specimens: sensitivity across serial specimens. Women and infants transmission study group. J. Pediatr. 129, 111–118 (1996).
  • Monleau M, Montavon C, Laurent C et al. Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing. J. Clin. Microbiol. 47, 1107–1118 (2009).
  • Sáez-Cirión A, Bacchus C, Hocqueloux L et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog. 9, e1003211 (2013).
  • Branson BM, Viall A, Marum E. Expanding HIV testing: back to the future. J. Acquir. Immune. Defic. Syndr. 63, S117–S121 (2013).
  • Branson BM, Pandori M. 2012 HIV diagnostics conference: the molecular diagnostics perspective. Expert Rev. Mol. Diagn. 13, 243–245 (2013).
  • Cornett JK, Kirn TJ. Laboratory diagnosis of HIV in adults: a review of current methods. Clin. Infect. Dis. (2013) ( In Press).
  • Balakrishnan P, Iqbal HS, Shanmugham S et al. Low-cost assays for monitoring HIV infected individuals in resource-limited settings. Indian J. Med. Res. 134, 823–834 (2011).
  • Bélec L, Bonn JP. Challenges in implementing HIV laboratory monitoring in resource-constrained settings: how to do more with less. Future Microbiol. 6, 1251–1260 (2011).
  • Zhang N, Appella DH. Advantages of Peptide Nucleic Acids as diagnostic platforms for detection of nucleic acids in resource-limited settings. J. Infect. Dis. 201, S42–S45 (2010).
  • Fokam J, Billong SC, Bissek AC et al. Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008–2010: lessons and challenges for low-resource settings. BMC Public Health 13, 308 (2013).
  • Incidence Assay Critical Path Working Group. More and better information to tackle HIV epidemics: towards improved HIV incidence assays. PLoS Med. 8, e1001045 (2011).
  • Pozzetto B, Garraud O. Risques viraux émergents en transfusion sanguine. Transfus. Clin. Biol. 18, 174–183 (2011).
  • Solheim BG. Pathogen reduction of blood components. Transfus. Apher. Sci. 39, 75–82 (2008).
  • Epstein JS. Alternative strategies in assuring blood safety: an overview. Biologicals 38, 31–35 (2010).
  • Fournier-Wirth C, Coste J. Nanotechnologies for pathogen detection: future alternatives? Biologicals 38, 9–13 (2010).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.